Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • IG study shows ASX traders most bullish since January 2022
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • IG study shows ASX traders most bullish since January 2022
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • IG study shows ASX traders most bullish since January 2022
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • IG study shows ASX traders most bullish since January 2022
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • IG study shows ASX traders most bullish since January 2022
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Keypath Education’s healthcare focus in the US and APAC boosts EBITDA
    • News

    Keypath Education’s healthcare focus in the US and APAC boosts EBITDA

    The global healthcare workforce is set to experience a squeeze, as the WHO estimates 10 million fewer workers by 2030. Lack of funding, disproportionate migration and low wages are just some of the reasons. This is a worrying picture, especially following the Covid-19 pandemic.  One company working towards remedying this is the global EdTech provider

    Read More
    Public
  • Netlinkz undertakes capital raising, secures contracts for its satellite division Starlink
    • News

    Netlinkz undertakes capital raising, secures contracts for its satellite division Starlink

    After a brief ASX suspension for not reporting its financials on time and incurring a loss of nearly $12 million in FY23, software company Netlinkz (ASX: NET) is looking to alter its course in FY24.  In Q1 FY24, the Company, which develops intelligent networking solutions, reported revenue of $6 million, marking a 34% uptick on

    Read More
    Public
  • Good Drinks Australia’s hospitality revenues boom even as overall beer market softens
    • News

    Good Drinks Australia’s hospitality revenues boom even as overall beer market softens

    By 2027, Australia’s beer market is set to be worth $25.11 billion, but with growing competition, it’s not enough to just sell great beer; companies must now sell an experience. That’s why Australian brewing company Good Drinks Australia (ASX: GDA) has left behind its pokies days to focus on more beer.  In Q1 FY24, the

    Read More
    Public
  • Anagenics reports steady earnings as beauty, health, and wellness spending remains intact
    • News

    Anagenics reports steady earnings as beauty, health, and wellness spending remains intact

    Despite evolving lifestyles encouraging more thoughtful financial choices, Australians remain committed to investing in premium beauty, health, and wellness products. The nation claims the 10th spot globally with US$84 billion spent on wellness items, while the national revenue in the Beauty & Personal Care market amounts to US$7.22 billion in 2023. Amidst economic challenges, Anagenics

    Read More
    Public
  • Bond market wakes up from its hypnosis | Economic update
    • News

    Bond market wakes up from its hypnosis | Economic update

    In Australia the release of the monthly CPI data upset the bond market that had been hypnotised by the relentless beat of the banks, media, and government messaging that inflation would keep declining. Although no one expects inflation to decline, or rise for the matter, in a linear manner, many in the market did the

    Read More
    Public
  • Adore Beauty’s loyalty programs prove fruitful with revenue bump in tough retail conditions
    • News

    Adore Beauty’s loyalty programs prove fruitful with revenue bump in tough retail conditions

    Aussies and discretionary spending have a love-hate relationship right now. Treating yourself to something nice can temporarily relieve the stress of ongoing financial pressures, but it’s often accompanied by a hint of guilt. Rising costs have hurt both consumers and businesses as they try to focus on strategies to stay afloat. For online beauty retailer

    Read More
    Public
  • Novatti seizes opportunity in Australia’s cashless transition as revenues rise while expenses drop
    • News

    Novatti seizes opportunity in Australia’s cashless transition as revenues rise while expenses drop

    Capitalising on the evolving financial landscape where the Reserve Bank of Australia is preparing for legislative changes in line with the direction of a cashless economy, digital payments company Novatti Group (ASX: NOV) has reported strengthened results with both revenue growth and expense reduction.  Over the past six months, Novatti has been undertaking a strategic

    Read More
    Public
  • Pointerra bags $500k contract with Enel, teams up with Carbonix and Emesent for its data analysis platform
    • News

    Pointerra bags $500k contract with Enel, teams up with Carbonix and Emesent for its data analysis platform

    After suffering some major financial blows in FY23, Data-as-a-Service (DaaS) company Pointerra (ASX: 3DP) is offering some relief for shareholders. The Company has signed three agreements, with Enel Colombia, Emesent and Carbonix, for its data tech. However, the contract value of only one of these is known, leaving investors wondering how these will impact revenue

    Read More
    Public
  • EVZ celebrates strong quarter with contract wins and engineering projects meeting delivery milestones
    • News

    EVZ celebrates strong quarter with contract wins and engineering projects meeting delivery milestones

    A bevy of large contract wins have delivered a financial boost to engineering and construction company EVZ (ASX: EVZ) which has expanded into new regions that are seeing growth thanks to major project works.  Brockman Engineering, a key subsidiary under EVZ, continues to make significant strides with their Viva Energy Strategic Storage project, located adjacent

    Read More
    Public
  • JATCorp sues Chinese competitor for calling products “fake”, posts 186% revenue increase in September quarter
    • News

    JATCorp sues Chinese competitor for calling products “fake”, posts 186% revenue increase in September quarter

    In any industry, there is more than one way to get ahead. One, of course, is doing your job and doing it better than anyone else. Another is destroying the competitors’ image so you are the only reliable option left standing. The latter is the approach Australia-Asia food trade specialist JATCorp (ASX: JAT)’s Chinese competitor

    Read More
    Public
  • «
  • ‹
  • 74
  • 75
  • 76
  • 77
  • 78
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.